Mihir Desai, M.D.

Mihir Desai, MD, is Director of the Stevan B. Streem Center for Endourology at the Glickman Urological and Kidney Institute of Cleveland Clinic, and Associate Professor of Surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr Desai’s clinical and research interests include stone disease, upper-urinary-tract obstruction, and laparoscopic and robotic surgery of the kidney, adrenal, prostate and bladder. 

Dr. Desai has over 110 publications in peer-reviewed literature on minimally invasive therapies of the urinary tract. In addition, he has written over 15 book chapters and has presented abstracts and videos in many national and international meetings.

He has done pioneering work in the field of treatment of ureteropelvic obstruction, “scarless” laparoscopic surgery and flexible robotic applications for endoscopy. Many of these research works have won honors and awards at scientific meetings.

Dr. Desai is also Director of the Endourology Fellowship of the Endourological Society. He is an invited reviewer of many reputed journals and serves on several scientific committees.

• Pioneered scarless laparoscopic surgery for various urological conditions
• Pioneered the use of flexible robotic technology for endoscopy
• Pioneered the technique of endopyeloplasty: a novel endoscopic method of treating uretero-pelvic (UPJ) obstruction

• American Urologic Association
• Endourological Society
• Society International d'Urologie (SIU)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 11/1/2008, Dr. Desai has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting.  Dr. Desai receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:

• Hansen Medical Inc.

Equity.  Dr. Desai owns stock or stock options in the following companies for activities as a founder, inventor, or consultant:

• Hansen Medical Inc.

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)